Zhu Ji-Wei, Wang Han-Ming, Aisikaer Muaitaer, Zhou Wen-Jun, Yang Tong-Tong, Aximujiang Kasimujiang
Xinjiang Medical University, Urumqi, 830017, China.
Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, 830017, China.
Chin J Integr Med. 2025 Jan 17. doi: 10.1007/s11655-025-3824-y.
Ulcerative colitis (UC) is a chronic, non-specific intestinal disease of unknown etiology, with high incidence rates worldwide. At present, Western medicine treatments have been associated with more adverse effects and poor efficacy. Chinese medicine (CM) is commonly used as an adjuvant treatment for the unique advantages in regulating immune function, repairing intestinal mucosa, and alleviating intestinal inflammation. At the same time, network pharmacology is also providing new ideas and innovations about CM and development of new drugs. This review systematically discusses the progress of research regarding UC treatment using CM, with a main focus on intestinal flora balance, intestinal mucosal barrier, CM enema, acupuncture therapy, and acupoint embedding. This study provides new ideas that clarify the therapeutic targets of UC.
溃疡性结肠炎(UC)是一种病因不明的慢性非特异性肠道疾病,在全球范围内发病率较高。目前,西医治疗不良反应较多且疗效不佳。中药因其在调节免疫功能、修复肠黏膜和减轻肠道炎症方面具有独特优势,常被用作辅助治疗。同时,网络药理学也为中药及新药研发提供了新的思路和创新。本综述系统地讨论了中药治疗UC的研究进展,主要聚焦于肠道菌群平衡、肠黏膜屏障、中药灌肠、针灸疗法和穴位埋线。本研究为阐明UC的治疗靶点提供了新思路。
Chin J Integr Med. 2025-1-17
Front Immunol. 2025-4-22
Zhongguo Zhong Yao Za Zhi. 2024-4
Front Pharmacol. 2023-10-24
J Ethnopharmacol. 2021-7-15
Front Immunol. 2023
Ann N Y Acad Sci. 2022-10
Cells. 2022-3-5